Printer Friendly

Agilent Technologies Joins BioIT Alliance.

SANTA CLARA, Calif. -- Agilent Technologies today announced that it has joined the BioIT Alliance, a cross-industry group working together to improve biomedical information technology.

The Alliance seeks to enable the pharmaceutical, biotechnology, equipment manufacturing and software industries to share best practices and develop standards for sharing biomedical data, improving collaboration and effectively managing life sciences knowledge. The early focus of the Alliance has been on addressing data-capture and data-integration challenges that hinder the adoption of emerging life science technologies.

As a member of the alliance, Agilent will collaborate with other members on proof-of-concept applications that address critical bottlenecks in biomedical discovery. Included is the alliance's latest proof-of-concept, the Biomarkers Project, designed to simplify the process of identifying and validating genomic biomarkers, the characteristics that indicate the presence of a disease or the likely efficacy of a drug.

"Agilent's involvement in the BioIT Alliance will further strengthen our commitment to enable biotechnology and pharmaceutical companies to effectively integrate data and insights from multiple disciplines and measurement platforms," said Nick Roelofs, vice president and general manager of life sciences, Agilent Technologies.

For more information about Agilent's life sciences and chemical analysis solutions, visit

About the BioIT Alliance

Formed in 2006, the BioIT Alliance is a cross-industry group working together to improve biomedical information technology on the Microsoft platform. Additional information about the BioIT Alliance can be found on the BioIT Alliance Web site at

About Agilent Technologies

Agilent Technologies Inc. (NYSE:A) is the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company's 20,000 employees serve customers in more than 110 countries. Agilent had net revenue of $5.1 billion in fiscal 2005. Information about Agilent is available on the Web at

NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available on the Agilent news site at
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 19, 2006
Previous Article:i2 Presents Complimentary Conference Featuring Presentations from Industry-Leading Automotive and Industrial Companies.
Next Article:Borland Names Gregory J. Wrenn as Senior Vice President and General Counsel.

Related Articles
Xilinx and Agilent Technologies Cooperate to Improve FPGA Designer Productivity; New Xilinx ChipScope ILA Tool Enhances Time-to-Market Advantage.
Cadence and Agilent Technologies Strike Alliance to Speed Electronic Design in Wireless, Wireline Industries.
TRADE NEWS: Agilent Technologies to Embed TIBCO Software's Integration Technology into Its OSS Solutions.
Agilent Technologies Names Treasurer Didier Hirsch as Controller; Current Controller Dotty Hayes to Join Intuit Inc.
Agilent Technologies Expands Alliance with Cadence to Provide Fast, Efficient Wireless Product Development Solutions.
Agilent Technologies and Synopsys Announce Industry-First Scan Diagnostics Reference Methodology.
Agilent Technologies Signs Agreement to Acquire the Business of Eagleware-Elanix, a Leading Provider of High-Frequency EDA Software.
Agilent Technologies Announces Plans to Expand EDA Product Portfolio to Include 3D Electromagnetic Simulation; New Product Direction Expected to...
Agilent Technologies Signs Agreement to Acquire Xpedion Design Systems, a Leading Provider of RFIC Simulation and Verification Software.
Agilent Technologies Signs Agreement to Acquire Acqiris, a Leading Provider of High-Speed Digitizers and Analyzers.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters